Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024

United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024. Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine. Long-term Growth Projection and Development: …

Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) – Analysis By Region, By Country: Opportunities and Forecast (2016-2021) – By Region, By Country

"Global Influenza Drugs and Vaccines Market – By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) – Analysis By Region, By Country: Opportunities and Forecast (2016-2021) – By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan)" A comprehensive research report created through extensive primary research (inputs …

Global Influenza Vaccine Market – Industry Trends, Opportunities and Forecasts to 2023

The global influenza vaccine market is projected to witness a CAGR of 6.93% during the forecast period to reach a total market size of US$4.613 billion by 2023, increasing from US$3.300 billion in 2018. The influenza, also called flu, is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and sometimes …

Vaccine Market by Technology (Live, Conjugate, Toxoid, Recombinant), Disease (Influenza, DTaP, HPV, Hepatitis, Rotavirus, TT, Polio, MMR, Varicella, Dengue, TB, Rabies), Route (IM, SC, ID, Oral), End User (Pediatric, Adult) & Type – Forecast to 2022

“Global vaccines market projected to grow at a CAGR of 7.5%” The vaccines market is expected to reach USD 49.27 billion by 2022 from USD 34.30 billion in 2017, at a CAGR of 7.5%. Rising prevalence of diseases, increasing government and nongovernment funding for vaccine development, and increasing investments by companies are driving the growth …

Seasonal Influenza Vaccines – Japan Drug Forecast and Market Analysis to 2025

Seasonal Influenza Vaccines – Japan Drug Forecast and Market Analysis to 2025 Summary Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses, designated as influenza Type A, B, and C. The infection’s rapid onset and potential for high morbidity and mortality, particularly in high-risk …

Seasonal Influenza Vaccines – 5EU Drug Forecast and Market Analysis to 2025

Seasonal Influenza Vaccines – 5EU Drug Forecast and Market Analysis to 2025 Summary Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses, designated as influenza Type A, B, and C. The infection’s rapid onset and potential for high morbidity and mortality, particularly in high-risk …

PharmaPoint: Seasonal Influenza Vaccines – Global Drug Forecast and Market Analysis to 2025

Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, B, and C. The infection’s rapid onset and potential for high morbidity and mortality, particularly in high-risk patient populations such as the elderly and young children, make prompt and effective …

Seasonal Influenza Vaccines – US Drug Forecast and Market Analysis to 2025

Seasonal Influenza Vaccines – US Drug Forecast and Market Analysis to 2025 Summary Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses, designated as influenza Type A, B, and C. The infection’s rapid onset and potential for high morbidity and mortality, particularly in high-risk …

Seasonal Influenza Vaccine Market Size, Country Outlook, Vaccination Analysis, Pipeline Insights, Clinical Trials Statement, Deals Type, Regulatory, Price Trends, Competitive Strategies and Forecast, 2016 to 2022

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against seasonal influenza, introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most countries. The barriers limiting the growth of the influenza market include limited patient awareness regarding …

Global Influenza Vaccines Market and Forecast to 2021 – Size, Share, Growth and Trends Analysis

The global influenza vaccines market is anticipated to reach nearly US$ 5 Billion by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination …